Home
Robin Shane Readnour, Director: AN2 Therapeutics ANTX Buy · Filed 24/11/27
Trade details
- Type
- Insider buy
- Amount
- $35,500
- Shares · price
- 25,000 sh · $1.42 a share
- Held after
- 552,288 sh
- Trade date
- 24/11/27
- Filed
- 24/11/27
- Days to filing
- 0 days
First buy since 2023
- Insiders buying this week
- 2 insiders
- Holding change
- +4.7%
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 24/10/28~24/12/27Robin Shane Readnour's recent trades
- Robin Shane Readnour
Planned sale10b5-1 planAN2 Therapeutics
Planned sale10b5-1 planAN2 Therapeutics
ANTX
$6.1M
1,012,000 sh
$6.1M
Filed 08/17
Traded 08/17
- Robin Shane Readnour
BuyAN2 Therapeutics
BuyAN2 Therapeutics
ANTX
$26.4K
18,483 sh
$26.4K
Filed 24/12/10
Traded 24/12/09
- Robin Shane Readnour
BuyAN2 Therapeutics
BuyAN2 Therapeutics
ANTX
$18.4K
12,711 sh
$18.4K
Filed 24/12/10
Traded 24/12/06
- Robin Shane Readnour
BuyAN2 Therapeutics
BuyAN2 Therapeutics
ANTX
$17.6K
12,289 sh
$17.6K
Filed 24/12/10
Traded 24/12/09
- Robin Shane Readnour
BuyAN2 Therapeutics
BuyAN2 Therapeutics
ANTX
$9,450
6,517 sh
$9,450
Filed 24/12/10
Traded 24/12/06